Propanc Biopharma, Inc.

Healthcare · Biotechnology · Australia

Last price 1.84 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.16M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research and collaboration agreement with the University of Jaén, to undertake research activities for the POP1 Program and the Univers...